Zacks Investment Research
25 Sept 2026, 22:51 UTC · 1h ago
Verdict
Headline takes no side. We score MSTR +0.20 across three claims — slightly bullish.
+0.20slightly bullish
More positive than 54% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Strategy's upcoming quarterly EPS is projected at $21.5, a 155.34% increase over the prior-year quarter.
Priced inconsensus estimate
So whatThis represents a significant swing from the full-year projected loss of $23.74 per share.
More positive than 93% of claims this week
Full-year earnings for Strategy are projected at -$23.74 per share, a 55.88% decrease from the previous year.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inZacks Consensus Estimates
So whatThe projected annual loss suggests that the upcoming quarterly beat will not be enough to offset FY2026 losses.
More negative than 86% of claims this week
Consensus revenue for the upcoming quarter is estimated at $130.4 million, up 1.33% year-over-year.
Priced inconsensus estimate
So whatFlat revenue growth alongside a 155% EPS jump indicates the earnings growth is likely driven by non-operating items or cost cuts rather than organic sales.
More positive than 44% of claims this week
Which stocks this story touches
More positive than 54% of ticker scores this week
Projected EPS for the upcoming quarter shows a significant 155.34% increase compared to the previous year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
MSTR hasn't traded since this ran. Last close $158.61 (Sep 25); the reaction starts at the next open.
MSTR chart →